ABSTRACT TOPICS

  1. Safety of COVID-19 vaccines and therapies and their global introduction
  2. Good Pharmacovigilance Practices and efforts of regulatory harmonization in PV
  3. Engaging patient and communities in pharmacovigilance
  4. Collaboration between stakeholders to improve pharmacovigilance systems. 
  5. Vaccine safety surveillance and pharmacovigilance in Public Health Programmes
  6. Harmonising safety surveillance across classes of health products 
  7. Integrating safety data from different sources
  8. Global vs regional and country perspectives in pharmacovigilance
  9. New approaches to ensure the safe use of medicines. 
  10. Benefits vs Risks of medicines in pregnancy
  11. Promising use of new technologies and methods in pharmacovigilance
  12. Risk Minimization interventions: systematic approaches to measure the impact of PV activities
  13. Miscellaneous

#ISOP2021@ISOPONLINE

“Activities and stakeholders
coming together for more effective systems”.

PARTNERS

CONTACT

REGISTER YOUR INTEREST
ISoP 2021
c/o C-IN
5. kvetna 65
140 21 Prague 4, Czech Republic
FOR ISOP 2021
EMAIL US AT info@isop2021oman.org

ISOP 2021 Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301
Copyright © 2020 c-in.eu | info@isop2021oman.org